Gilead Sciences   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Foster City CA United States (1987)

Organization Overview

First Clinical Trial
1999
NCT00196599
First Marketed Drug
1996
cidofovir (vistide)
First NDA Approval
1996
cidofovir (vistide)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Forty-Seven/Gilead | GILEAD | Gilead, Inc. Investigator Sponsored Research | Gilead Sciences | GILEAD SCIENCES | Gilead Sciences GmbH | GILEAD SCIENCES INC | Gilead Sciences, Ltd. | Gilead Sciences, S.L. | Gilead Sciences Study Director | Kite, A Gilead Company | Senior Clinical Research Scientist, Gilead Sciences